Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 5:1–18. doi: 10.1017/S1049023X20001533

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© World Association for Disaster and Emergency Medicine 2021

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Proportion of the Causative Agent Exposure According to the Age Groups Over the Period (March through May) of 2016-2020.

Abbreviation: CNS, Central Nervous System.

Anticholinesterase compounds exposure presented as follows: adults (57.0%), adolescents (18.6%), toddlers (16.2%), children (7.9%), and infants (0.3%).

Alcohols and drugs of abuse exposure presented as follows: adults (61.0%), toddlers (26.8%), adolescents (7.3%), children (3.7%), and infants (1.2%).

Analgesic antipyretic exposure presented as follows: adults (43.4%), toddlers (29.5%), adolescents (19.7%), children (5.7%), and infants (1.7%).

Phosphide exposure presented as follows: adults (50.0%), adolescents (35.1%), toddlers (9.1%), children (5.2%), infants (0.3%), and older adults (0.3%).

Corrosives and hydrocarbons exposure presented as follows: toddlers (65.3%), adults (14.3%), children (12.2%), and adolescents (8.2%).

CNS depressants exposure presented as follows: adults (54.6%), adolescents (21.1%), toddlers (16.4%), children (6.6%), and infants (1.3%).

Antipsychotics exposure presented as follows: adults (33.9%), toddlers (23.8%), adolescents (21.4%), children (18.5%), and infants (2.4%).

Antidepressants exposure presented as follows: adults (49.1%), adolescents (24.5%), children (15.1%), toddlers (9.4%), and infants (1.9%).

Cardiovascular and xanthine derivatives exposure presented as follows: adults (37.3%), adolescents (27.0%), toddlers (25.5%), children (9.7%), and infants (0.5%).

Other non-classified toxic exposure presented as follows: adults (37.4%), toddlers (32.0%), adolescents (19.0%), children (10.8%), and infants (0.5%).